306.36
price down icon1.92%   -6.00
pre-market  Pre-market:  305.63   -0.73   -0.24%
loading
Bio Rad Laboratories Inc stock is traded at $306.36, with a volume of 370.35K. It is down -1.92% in the last 24 hours and down -12.89% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$312.36
Open:
$314.64
24h Volume:
370.35K
Relative Volume:
2.21
Market Cap:
$8.58B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-11.21
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
-11.31%
1M Performance:
-12.89%
6M Performance:
-6.02%
1Y Performance:
-3.08%
1-Day Range:
Value
$300.63
$315.00
1-Week Range:
Value
$300.63
$345.70
52-Week Range:
Value
$262.12
$387.99

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name
Name
Bio Rad Laboratories Inc
Name
Phone
(510) 724-7000
Name
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Name
Employee
8,030
Name
Twitter
@BioRadLifeSci
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
BIO's Discussions on Twitter

Compare BIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
BIO
Bio Rad Laboratories Inc
306.36 8.58B 2.58B -778.69M 223.75M -27.33
Medical Devices icon
ABT
Abbott Laboratories
131.79 228.58B 41.95B 13.40B 6.49B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
106.14 156.43B 16.75B 1.85B 1.89B 1.25
Medical Devices icon
SYK
Stryker Corp
388.37 147.01B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
92.20 118.23B 33.00B 4.29B 5.50B 3.27
Medical Devices icon
EW
Edwards Lifesciences Corp
76.00 44.82B 5.72B 4.17B 490.10M 6.97

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-01-24 Upgrade Citigroup Neutral → Buy
Aug-28-24 Initiated Wells Fargo Equal Weight
Jun-03-24 Resumed Jefferies Hold
Apr-03-24 Downgrade Citigroup Buy → Neutral
Dec-07-23 Initiated UBS Buy
Jun-16-23 Initiated Wells Fargo Overweight
Dec-07-22 Initiated RBC Capital Mkts Outperform
Aug-25-22 Initiated Credit Suisse Outperform
Jan-28-22 Reiterated Citigroup Buy
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Buy
Oct-17-18 Initiated Goldman Buy
Sep-20-18 Initiated Morgan Stanley Equal-Weight
Feb-16-18 Downgrade CL King Buy → Neutral
Jul-13-17 Initiated Wells Fargo Outperform
Jun-28-17 Upgrade Deutsche Bank Hold → Buy
Jan-18-17 Initiated Deutsche Bank Hold
Oct-13-16 Initiated CL King Buy
May-06-15 Reiterated Jefferies Buy
Dec-18-09 Initiated Maxim Group Buy
Nov-06-09 Initiated Jefferies & Co Buy
Jul-17-09 Initiated Soleil Buy
Sep-26-07 Initiated Banc of America Sec Buy
Feb-23-07 Downgrade Robert W. Baird Outperform → Neutral
View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

pulisher
04:46 AM

Bio-Rad Laboratories, Inc. (NYSE:BIO) Stake Cut by Allspring Global Investments Holdings LLC - MarketBeat

04:46 AM
pulisher
02:57 AM

Enzyme Linked Immunosorbent Assay Market Growth, Share, - openPR

02:57 AM
pulisher
02:22 AM

Bio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance

02:22 AM
pulisher
01:04 AM

Q4 EPS Forecast for Bio-Rad Laboratories Boosted by Analyst - MarketBeat

01:04 AM
pulisher
12:56 PM

Chromatography Systems Market: In-Depth Exploration of Key - openPR

12:56 PM
pulisher
12:51 PM

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies - BioSpace

12:51 PM
pulisher
12:38 PM

Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results - BioSpace

12:38 PM
pulisher
12:19 PM

Chemiluminescence Imaging Market Booming Innovation: Witness - openPR

12:19 PM
pulisher
Feb 13, 2025

Bio-Rad Laboratories Reports 2024 Earnings and Strategic Plans - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Strategic Financial Concepts LLC Invests $3.56 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

Bio-Rad: Q4 Earnings Snapshot - Thehour.com

Feb 13, 2025
pulisher
Feb 13, 2025

Earnings call transcript: Bio-Rad Q4 2024 results miss forecasts - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Bio-Rad Labs stock down 4% as Q4 revenue and guidance miss expectations - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Bio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Bio-Rad set to acquire Stilla Technologies By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 13, 2025

Bio-Rad set to acquire Stilla Technologies - Investing.com

Feb 13, 2025
pulisher
Feb 13, 2025

Bio-Rad offers to acquire digital PCR developer Stilla Technologies - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Oversold Conditions For Bio-Rad Laboratories - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Major PCR Tech Acquisition: Bio-Rad Sets Sights on Stilla's Next-Gen Digital Platform - StockTitan

Feb 13, 2025
pulisher
Feb 13, 2025

Wells Fargo & Company Cuts Bio-Rad Laboratories (NYSE:BIO) Price Target to $345.00 - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Immunoassay Market Size Expected to Reach USD 53,970 Million by 2034 with 5.1% CAGR | Statifacts Report - GlobeNewswire Inc.

Feb 13, 2025
pulisher
Feb 13, 2025

Nuclear Pore Membrane Market Booming Innovation: Future - openPR

Feb 13, 2025
pulisher
Feb 13, 2025

Van ECK Associates Corp Cuts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Sumitomo Mitsui Trust Group Inc. Decreases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

Lecap Asset Management Ltd. Takes $510,000 Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownWhat's Next? - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Bio-Rad Laboratories (NYSE:BIO) Shares Down 4.2%Here's What Happened - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

Bio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Feb 12, 2025
pulisher
Feb 11, 2025

Oncocyte secures $29.1 million to advance FDA assay - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Molecular Quality Control Market Deep Research Report with - openPR

Feb 11, 2025
pulisher
Feb 10, 2025

Oncocyte Prices $29 Million Stock Offerings -February 10, 2025 at 12:41 pm EST - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Oncocyte Secures $29.1Mln Funding Led By Bio-Rad To Advance Transplant Diagnostics, Stock Down - Nasdaq

Feb 10, 2025
pulisher
Feb 09, 2025

Bio-Rad Laboratories (BIO) Projected to Post Earnings on Thursday - MarketBeat

Feb 09, 2025
pulisher
Feb 07, 2025

Antinuclear antibody test market Size, Share, Industry - openPR

Feb 07, 2025
pulisher
Feb 07, 2025

Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Cell Processing Instrument Market Competitive Dynamics: - openPR

Feb 07, 2025
pulisher
Feb 07, 2025

KBC Group NV Sells 814 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

DAVENPORT & Co LLC Acquires 27,780 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

Biopharmaceutical Bioseparation Systems Global Report 2025: Market to Benefit from Rising Demand for Monoclonal Antibodies, Forecast to Hit $32.6 Billion by 2030 - Yahoo Finance

Feb 07, 2025
pulisher
Feb 07, 2025

Robeco Institutional Asset Management B.V. Has $2.55 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

Feb 07, 2025
pulisher
Feb 06, 2025

Bio-Rad Launches Dye Label Kits for Antibody Conjugation - Contract Pharma

Feb 06, 2025
pulisher
Feb 06, 2025

Lab-on-Chip Application Market Statistics, Competitive - openPR

Feb 06, 2025
pulisher
Feb 06, 2025

Blood Market to Grow by USD 2.60 Billion (2024-2028) with Rising Number of Hospitals & Blood Banks Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday - Defense World

Feb 06, 2025
pulisher
Feb 05, 2025

Bio-Rad Laboratories, Inc. (NYSE:BIO) Sees Significant Increase in Short Interest - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

Clinical Microbiology Market Generated Opportunities, Future - openPR

Feb 05, 2025
pulisher
Feb 05, 2025

Janney Montgomery Scott LLC Sells 130 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year? - MSN

Feb 04, 2025

Bio Rad Laboratories Inc Stock (BIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$99.91
price up icon 0.93%
medical_devices STE
$219.23
price up icon 0.05%
medical_devices PHG
$28.61
price up icon 1.49%
$84.09
price up icon 0.26%
$93.48
price up icon 8.82%
medical_devices EW
$76.00
price up icon 0.24%
Cap:     |  Volume (24h):